152 related articles for article (PubMed ID: 33254511)
1. Hypothesizing the therapeutic potential of mesenchymal stem cells in oral submucous fibrosis.
Kheur S; Sanap A; Kharat A; Gupta AA; Raj AT; Kheur M; Bhonde R
Med Hypotheses; 2020 Nov; 144():110204. PubMed ID: 33254511
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and Fibrogenesis in Oral Submucous Fibrosis: A Viewpoint.
Choudhari SS; Kulkarni DG; Patankar S; Kheur SM; Sarode SC; Sarode GS; Patil S
J Contemp Dent Pract; 2018 Feb; 19(2):242-245. PubMed ID: 29422478
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells in the management of oral submucous fibrosis-An enigma to be solved.
Kizhakkoottu S; Ramani P; Tilakaratne WM
J Oral Pathol Med; 2024 May; 53(5):275-276. PubMed ID: 38685571
[No Abstract] [Full Text] [Related]
4. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
5. Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy.
Shih YH; Wang TH; Shieh TM; Tseng YH
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31208114
[TBL] [Abstract][Full Text] [Related]
6. Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis.
Pant I; Kumar N; Khan I; Rao SG; Kondaiah P
PLoS One; 2015; 10(6):e0129252. PubMed ID: 26107172
[TBL] [Abstract][Full Text] [Related]
7. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
8. Editorial. Oral submucous fibrosis: revised hypotheses as to its cause.
Rajendran R; Sukumaran A
J Contemp Dent Pract; 2013 Sep; 14(5):i-iii. PubMed ID: 24685814
[TBL] [Abstract][Full Text] [Related]
9. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis.
Das RK; Anura A; Pal M; Bag S; Majumdar S; Barui A; Chakraborty C; Ray AK; Sengupta S; Paul RR; Chatterjee J
Exp Mol Pathol; 2013 Dec; 95(3):259-69. PubMed ID: 23994666
[TBL] [Abstract][Full Text] [Related]
10. Oral submucous fibrosis in Asian countries.
Peng Q; Li H; Chen J; Wang Y; Tang Z
J Oral Pathol Med; 2020 Apr; 49(4):294-304. PubMed ID: 31310693
[TBL] [Abstract][Full Text] [Related]
11. Photobiomodulation therapy inhibits oral submucous fibrosis in mice.
Chiang MH; Lee KT; Chen CH; Chen KK; Wang YH
Oral Dis; 2020 Oct; 26(7):1474-1482. PubMed ID: 32391600
[TBL] [Abstract][Full Text] [Related]
12. [Collagen content and types in oral submucous fibrosis].
Huang IY; Shieh TY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Mar; 5(3):162-71. PubMed ID: 2733074
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways regulated by areca nut in the etiopathogenesis of oral submucous fibrosis.
Kondaiah P; Pant I; Khan I
Periodontol 2000; 2019 Jun; 80(1):213-224. PubMed ID: 31090136
[TBL] [Abstract][Full Text] [Related]
14. The role of epithelial-mesenchymal transition in oral squamous cell carcinoma and oral submucous fibrosis.
Yanjia H; Xinchun J
Clin Chim Acta; 2007 Aug; 383(1-2):51-6. PubMed ID: 17537414
[TBL] [Abstract][Full Text] [Related]
15. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
[TBL] [Abstract][Full Text] [Related]
16. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.
Shen YW; Shih YH; Fuh LJ; Shieh TM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33008091
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the oral mucosa after release of submucous fibrosis and bilateral small radial forearm flap reconstruction.
Celik N; Wei FC; Chang YM; Yang WG; Chen DJ; Tsai CY
Plast Reconstr Surg; 2002 Jul; 110(1):34-8. PubMed ID: 12087228
[TBL] [Abstract][Full Text] [Related]
18. YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis.
Li J; Yao M; Zhu X; Li Q; He J; Chen L; Wang W; Zhu C; Shen T; Cao R; Fang C
J Dent Res; 2019 Jul; 98(8):920-929. PubMed ID: 31282845
[TBL] [Abstract][Full Text] [Related]
19. Current protocols in the management of oral submucous fibrosis: An update.
Arakeri G; Rai KK; Boraks G; Patil SG; Aljabab AS; Merkx MAW; Carrozzo M; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):418-423. PubMed ID: 28391602
[TBL] [Abstract][Full Text] [Related]
20. The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review.
Wadhwan V; Venkatesh A; Reddy V; Malik S
J Oral Maxillofac Pathol; 2019; 23(2):257-266. PubMed ID: 31516233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
